Page last updated: 2024-10-31

mianserin and Lung Diseases

mianserin has been researched along with Lung Diseases in 2 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Lung Diseases: Pathological processes involving any part of the LUNG.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hohlfeld, SK1
Günthard, HF1
Zeitz, J1
Locher, P1
Bachli, E1
Brooks, AM1

Other Studies

2 other studies available for mianserin and Lung Diseases

ArticleYear
Progressive multi-focal leukoencephalopathy as a rare lethal complication in untreated sarcoidosis.
    BMJ case reports, 2012, Jun-28, Volume: 2012

    Topics: Adrenergic alpha-Antagonists; Adult; DNA, Viral; Fatal Outcome; Humans; JC Virus; Leukoencephalopath

2012
Pulmonary reaction to mianserin (Tolvon)
    The Medical journal of Australia, 1980, Aug-23, Volume: 2, Issue:4

    Topics: Adult; Dibenzazepines; Humans; Lung Diseases; Male; Mianserin

1980